ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 861 filers reported holding ISHARES TR in Q4 2020. The put-call ratio across all filers is 1.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,510 | -3.7% | 642 | 0.0% | 0.04% | -4.3% |
| Q2 2023 | $81,508 | -1.7% | 642 | 0.0% | 0.05% | -11.3% |
| Q1 2023 | $82,921 | -1.6% | 642 | 0.0% | 0.05% | -3.6% |
| Q4 2022 | $84,288 | +12.4% | 642 | 0.0% | 0.06% | -1.8% |
| Q3 2022 | $75,000 | -1.3% | 642 | 0.0% | 0.06% | +1.8% |
| Q2 2022 | $76,000 | -9.5% | 642 | 0.0% | 0.06% | +3.8% |
| Q1 2022 | $84,000 | -14.3% | 642 | 0.0% | 0.05% | -10.2% |
| Q4 2021 | $98,000 | -5.8% | 642 | 0.0% | 0.06% | -13.2% |
| Q3 2021 | $104,000 | -1.0% | 642 | 0.0% | 0.07% | -1.4% |
| Q2 2021 | $105,000 | +8.2% | 642 | 0.0% | 0.07% | -2.8% |
| Q1 2021 | $97,000 | 0.0% | 642 | 0.0% | 0.07% | -1.4% |
| Q4 2020 | $97,000 | +11.5% | 642 | 0.0% | 0.07% | 0.0% |
| Q3 2020 | $87,000 | 0.0% | 642 | 0.0% | 0.07% | -7.7% |
| Q2 2020 | $87,000 | +26.1% | 642 | 0.0% | 0.08% | +21.9% |
| Q1 2020 | $69,000 | -10.4% | 642 | 0.0% | 0.06% | -9.9% |
| Q4 2019 | $77,000 | – | 642 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |